Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,587,867
  • Shares Outstanding, K 36,030
  • Annual Sales, $ 704,590 K
  • Annual Income, $ 73,190 K
  • 60-Month Beta 1.50
  • Price/Sales 4.53
  • Price/Cash Flow 27.98
  • Price/Book 5.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.75
  • Number of Estimates 5
  • High Estimate 0.76
  • Low Estimate 0.74
  • Prior Year 0.76
  • Growth Rate Est. (year over year) -1.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.89 +20.14%
on 01/27/20
101.12 -1.52%
on 02/20/20
+8.50 (+9.33%)
since 01/21/20
3-Month
73.53 +35.43%
on 11/22/19
101.12 -1.52%
on 02/20/20
+24.84 (+33.24%)
since 11/21/19
52-Week
50.14 +98.60%
on 03/08/19
101.12 -1.52%
on 02/20/20
+30.41 (+43.96%)
since 02/21/19

Most Recent Stories

More News
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2019 Financial Results on February 24, 2020

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2019 financial results after the market close on Monday, February 24, 2020. The...

MEDP : 99.58 (-0.34%)
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will present at the following investor conference in November:

MEDP : 99.58 (-0.34%)
Medpace (MEDP) Q3 Earnings Meet Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MEDP : 99.58 (-0.34%)
Medpace: 3Q Earnings Snapshot

CINCINNATI (AP) _ Medpace Holdings Inc. (MEDP) on Monday reported third-quarter net income of $24 million.

MEDP : 99.58 (-0.34%)
Medpace Holdings, Inc. Reports Third Quarter 2019 Results

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the third quarter ended September 30, 2019.

MEDP : 99.58 (-0.34%)
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MEDP : 99.58 (-0.34%)
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

Style Box ETF report for FYC

FYC : 47.89 (-1.41%)
LSCC : 19.03 (-0.83%)
VBK : 207.33 (-1.40%)
IWO : 222.19 (-1.31%)
SHAK : 74.80 (-2.40%)
MEDP : 99.58 (-0.34%)
Should Teladoc Worry About Amazon's Virtual Healthcare Move?

Teladoc (TDOC) might face increasing competition from Amazon in virtual healthcare space once the latter expands its presence.

LHCG : 155.00 (-1.54%)
TDOC : 113.54 (-2.04%)
MEDP : 99.58 (-0.34%)
AVDR : 22.99 (+0.48%)
The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia

The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia

LAD : 129.39 (-1.26%)
MRCY : 85.09 (-0.70%)
PFSI : 35.47 (+1.14%)
RH : 236.45 (-3.79%)
MEDP : 99.58 (-0.34%)
Medpace Holdings, Inc. to Report Third Quarter 2019 Financial Results on October 28, 2019

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its third quarter 2019 financial results after the market close on Monday, October 28, 2019. The Company will host...

MEDP : 99.58 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MEDP with:

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

2nd Resistance Point 101.56
1st Resistance Point 100.57
Last Price 99.58
1st Support Level 98.42
2nd Support Level 97.26

See More

52-Week High 101.12
Last Price 99.58
Fibonacci 61.8% 81.65
Fibonacci 50% 75.63
Fibonacci 38.2% 69.61
52-Week Low 50.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar